Innovation Pharmaceuticals Inc (IPIX)

[drupac]

"There were six severe adverse events (SAE) reported across the study, none of which were considered related to Brilacidin by the principal investigator. Biostatistics are being reviewed and will be made available to shareholders over the coming weeks."

Atleast we get a timeline when the data will be released